not tagged
not tagged
[]
lots of talk at #esmo22 re: adjuvant/periop tx for #kidneycancer. our survey has over a dozen questions related to adjuvant tx: including how patients rate risk of recurrence, understanding of tx benefits, and most important factors in tx decision making. results coming soon!
A nonprofit raising research funding to cure #kidneycancer